And doctors are here to discuss possible solutions if you have concerns, questions, or think you may benefit from hormone therapy and/or weight loss medication
Laudenslager also suggests for people taking GLP-1s
therefore, the following individuals should not use Zepbound: People with a personal or family history of medullary thyroid carcinoma (MTC) People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Additionally, anyone who is allergic to Zepbound or any of its ingredients should not use this drug
Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers)
These injections are typically administered subcutaneously (under the skin) in areas like the abdomen, thigh, or upper arm
These substances are used in small doses (mostly 1 mg anastrozole, 2.5 mg letrozole, and 12.5 mg exemestane)